The following is a summary of “Longitudinal integrated proteomic and metabolomic skin changes in atopic dermatitis patients ...
Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.
The success of dupilumab, marketed by Sanofi under the ... particularly in atopic dermatitis (AD), where it is widely regarded as the gold standard (1 Trusted Source Sanofi to increase ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback